Prothena Corp PLC (PRTA)

29.06 -1.68 (-5.48%) USD  |  NASDAQ  |  Sep 26, 16:00
29.06 0.00 (0.00%) After-Hours: 17:45
More

Prothena News

News

Headline
Wire
Time (ET)
Prothena (PRTA) Down 16.9% Since Last Earnings Report: Can It Rebound?
Yahoo
09/07 11:30
Prothena to Participate in Upcoming Healthcare Conferences
Globe Newswire
09/01 16:20
Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors
Yahoo
09/01 16:05
Insider Sell: Prothena Corp
MT Newswires
08/15 07:02
Prothena (PRTA) Q2 Earnings Miss, Pipeline Progress in Focus
Yahoo
08/09 10:37
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates
Yahoo
08/08 17:45
-- Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q2 Revenue $1.3M
MT Newswires
08/08 16:13
Prothena Reports Second Quarter 2022 Financial Results and Business Highlights
Yahoo
08/08 16:05
Insider Sell: Prothena
MT Newswires
08/08 09:06
Notable earnings after Monday's close
SA Breaking News
08/07 17:35
Prothena (NASDAQ:PRTA) delivers shareholders strong 57% CAGR over 3 years, surging 6.6% in the last week alone
Yahoo
08/07 10:27
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
08/02 16:05
Prothena to Report Second Quarter 2022 Financial Results on August 8th
Globe Newswire
08/01 16:05
Insider Sell: Prothena
MT Newswires
07/25 07:08
Electric vehicle stocks race higher ahead of Tesla earnings
SA Breaking News
07/20 11:25
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
07/01 16:16
JMP Securities Adjusts Prothena's Price Target to $50 from $77, Keeps Market Outperform Rating
MT Newswires
05/25 09:42
-- Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $1.2M
MT Newswires
05/05 16:54
Prothena Reports First Quarter 2022 Financial Results and Business Highlights
Globe Newswire
05/05 16:05
--RBC Slashes Price Target on Prothena to $45 From $82, Keeps Outperform-Speculative Risk Rating
MT Newswires
05/02 08:15
Prothena to Report First Quarter 2022 Financial Results on May 5th
Globe Newswire
04/28 16:05
Prothena Secures Fast Track Designation For Potential Alzheimer's Disease Treatment PRX012
MT Newswires
04/26 10:36
Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease
Globe Newswire
04/26 08:30
Prothena Secures US FDA Approval for Its Investigational New Drug Application of Drug Candidate for Alzheimer's Disease
MT Newswires
03/28 10:29
Prothena's PRX012 for Alzheimer’s gets FDA nod to enter clinical trial
SA Breaking News
03/28 09:37
Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022
Globe Newswire
03/16 05:30
FTCH, YNDX and MQ among pre market gainers
SA Breaking News
02/25 08:48
Prothena Pares Q4 Loss, Misses Estimates; Revenue Gain Also Trails Street View
MT Newswires
02/17 17:15
-- Earnings Flash (PRTA) PROTHENA CORPORATION Reports Q4 Revenue $1.17M, vs. Street Est of $11.8M
MT Newswires
02/17 16:08
Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights
Globe Newswire
02/17 16:05
Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022
Globe Newswire
02/10 16:05
Proterra, Scale Microgrid to install solar-powered microgrid for Santa Clara VTA
SA Breaking News
01/27 10:11
Puma Biotechnology, Marin Software lead aftermarket gainers; Vaxcyte among losers
SA Breaking News
01/12 17:14
Biogen plans flood of public comments in response to Medicare decision - Endpoints
SA Breaking News
01/12 10:44
Immuron, Immix lead healthcare gainers; Philips, Prothena among losers
SA Breaking News
01/12 10:02
Insider Sell: Prothena Corp Public Ltd
MT Newswires
01/06 11:06
Insider Sell: Prothena
MT Newswires
11/29 14:23
Prothena Shares Rise After JMP Securities Begins Coverage at Market Outperform
MT Newswires
11/19 14:27
JMP Securities Starts Prothena at Market Outperform With $77 Price Target
MT Newswires
11/19 07:18
-- Earnings Flash (PRTA) PROTHENA CORPORATION Reports Q3 Revenue $139.2M, vs. Street Est of $140M
MT Newswires
11/04 16:06
Insider Sell: Prothena Corp Public Ltd
MT Newswires
10/25 09:32
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
10/01 16:30
Prothena Names Brandon Smith as Chief Operating Officer
MT Newswires
10/01 16:19
RBC Boosts Price Target on Prothena to $82 From $59, Sees Higher Success Probability for Alzheimer's Portfolio, Keeps Outperform, Speculative Risk
MT Newswires
09/30 08:58
Oppenheimer Adjusts Prothena PT to $100 From $90, Maintains Outperform Rating
MT Newswires
09/27 11:38
Oppenheimer Adjusts Prothena's Price Target to $100 from $90, Keeps Outperform Rating
MT Newswires
09/27 11:29
--Fox Advisors Initiates Coverage on Prothena With Overweight Rating
MT Newswires
09/20 13:47
Cantor Fitzgerald Adjusts Price Target on Prothena to $103 From $70, Maintains Overweight Rating
MT Newswires
09/17 11:57
Oppenheimer Adjusts Prothena PT to $90 From $82 on Increased Optimism for the Company's Neuroscience Portfolio, Maintains Outperform Rating
MT Newswires
09/14 11:10
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
09/03 16:05
Prothena to Participate in Upcoming September Healthcare Conferences
Globe Newswire
09/01 16:05
Tesla and Chinese EV stocks slammed by regulatory concerns
SA Breaking News
08/16 10:21
--Oppenheimer Adjusts Prothena PT to $82 From $76, Maintains Outperform Rating
MT Newswires
08/09 11:43
-- Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q2 Revenue $60.1M, vs. Street Est of $73.5M
MT Newswires
08/05 16:21
Prothena to Report Second Quarter 2021 Financial Results on August 5th
Globe Newswire
07/29 16:05
Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Conference 2021
Globe Newswire
07/20 16:05
RBC Capital Adjusts Prothena PT to $59 From $50, Maintains Outperform - Speculative Risk Rating
MT Newswires
07/19 09:04
Cantor Fitzgerald Adjusts Price Target on Prothena to $70 From $63, Maintains Overweight Rating
MT Newswires
07/15 12:26
Oppenheimer Adjusts Prothena PT to $76 From $54, Maintains Outperform Rating
MT Newswires
07/13 12:27
Citigroup Adjusts Price Target on Prothena to $72 From $57, Maintains Buy Rating
MT Newswires
07/13 09:55
HC Wainwright Adjusts Prothena's Price Target to $75 From $58, Keeps Buy Rating
MT Newswires
07/13 06:58
Prothena shares lag despite up to $1.2B deal with Novo Nordisk
SA Breaking News
07/12 14:45
Tempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losers
SA Breaking News
07/12 11:00
Prothena Sells ATTR Amyloidosis Program to Novo Nordisk
MT Newswires
07/12 09:34
Thinking about trading options or stock in Celldex Therapeutics, Tesla, Prothena Corp, Microsoft, or Annovis Bio?
PR Newswire
07/12 09:31
Novo Nordisk inks purchase deal for Prothena’s ATTR amyloidosis program
SA Breaking News
07/12 07:31
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme
Globe Newswire
07/12 07:00
Electric vehicle stocks rally as focus shifts to upside from infrastructure deal
SA Breaking News
06/28 11:03
Prothena secures $80M from Bristol Myers for US license to PRX005
SA Breaking News
06/24 08:55
Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and Development Collaboration
Globe Newswire
06/24 08:30
Sector Update: Health Care Stocks Finding Modest Support Ahead of Close
MT Newswires
06/18 16:02
Sector Update: Health Care Stocks Ailing Friday
MT Newswires
06/18 13:24
BofA Securities Upgrades Prothena to Neutral From Underperform; Price Target is $49
MT Newswires
06/18 07:19
CVAC, CAPR, NOVN and CLSD among midday movers
SA Breaking News
06/17 12:40
Midatech Pharma, Cellect Biotechnology leads healthcare gainers; CureVac, Novan among major losers
SA Breaking News
06/17 11:04
Thinking about trading options or stock in Prothena Corp, CureVac, Centene Corp, AMC, or Biogen?
PR Newswire
06/17 09:31
Prothena nears a four-year high with a Street high target from Jefferies
SA Breaking News
06/16 13:09
Thinking about trading options or stock in Prothena Corp, AT&T, MicroStrategy, General Electric, or Bank of America?
PR Newswire
06/16 09:31
Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?
PR Newswire
06/11 09:31
RBC Capital Adjusts Price Target on Prothena to $50 From $28, Maintains Outperform-Speculative Risk Rating
MT Newswires
06/11 09:04
Prothena to Participate in JMP Securities Life Sciences Conference on June 16
Globe Newswire
06/10 14:18
HC Wainwright Adjusts Prothena's Price Target to $58 From $33, Keeps Buy Rating
MT Newswires
06/10 07:20
Prothena price target raised at Oppenheimer after FDA nod for Biogen’s Alzheimer’s therapy
SA Breaking News
06/08 12:06
Could Lilly's donanemab, others for Alzheimer's get a boost from Biogen approval?
SA Breaking News
06/08 11:18
--Oppenheimer Adjusts Prothena's Price Target to $45 From $40, Maintains Outperform Rating
MT Newswires
06/01 10:01
Citigroup Starts Prothena at Buy With $39 Price Target
MT Newswires
05/26 09:42
Prothena adds Sanjiv Patel to its board of directors
SA Breaking News
05/20 16:23
Prothena Announces Appointment of Sanjiv Patel, MBBS, to its Board of Directors
Globe Newswire
05/20 16:05
--Oppenheimer Adjusts Prothena PT to $40 From $35, Maintains Outperform Rating
MT Newswires
05/12 10:16
Prothena Q1 Net Loss Widens, Revenue Rises
MT Newswires
05/11 16:30
Prothena EPS misses by $0.37, misses on revenue
SA Breaking News
05/11 16:16
-- Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $0.2M
MT Newswires
05/11 16:07
Prothena Reports First Quarter 2021 Financial Results and Provides Updated Financial Guidance and R&D Update
Globe Newswire
05/11 16:05
Prothena Begins Dosing in Study of Prasinezumab in Early Parkinson's Disease, Receives $60 Million Milestone Payment
MT Newswires
05/11 05:31
Prothena initiates dosing in Parkinson's disease trial; earns milestone payments from Roche
SA Breaking News
05/10 17:09
Prothena Announces Achievement of $60 Million Milestone From Roche for First Patient Dosed in Phase 2b Study of Prasinezumab in Early Parkinson’s Disease
Globe Newswire
05/10 16:05
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
05/07 16:05
Prothena to Report First Quarter 2021 Financial Results on May 11th
Globe Newswire
05/04 16:05
Prothena Reports Favorable Results From Early Study of PRX004 in Patients With Hereditary ATTR Amyloidosis
MT Newswires
04/19 04:11
Prothena's PRX004 shows benefits in neuropathy and cardiac function
SA Breaking News
04/19 00:10
Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021
Globe Newswire
04/18 15:05
Prothena Announces PRX004 Phase 1 Study Results Selected for Emerging Science Oral Presentation at AAN 2021
Globe Newswire
04/15 16:05
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
04/07 16:05
Prothena Names New Chief Medical Officer
MT Newswires
04/05 16:37
Prothena names new medical chief
SA Breaking News
04/05 16:25
Prothena Announces Appointment of Hideki Garren, MD, PhD, as Chief Medical Officer
Globe Newswire
04/05 16:05
Prothena closes nearly 17% higher after pricing offering; up another 3% post-market
SA Breaking News
03/24 17:12
Aptose Biosciences, Brainstorm Cell Therapeutics leads healthcare gainers; Benitec Biopharma, Second Sight Medical Products among major losers
SA Breaking News
03/24 11:00
Prothena Prices Offering at $20.75 Per Ordinary Share
MT Newswires
03/24 08:51
Prothena trades lower after pricing public offering
SA Breaking News
03/24 08:42
Prothena Announces Pricing of Public Offering of 3,500,000 Ordinary Shares
Globe Newswire
03/24 08:00
Prothena commences offering of common shares; stock down 6% after-hours
SA Breaking News
03/23 16:56
Prothena Kicks Off Offering of Ordinary Shares
MT Newswires
03/23 16:35
Prothena Announces Proposed Offering of Ordinary Shares
Globe Newswire
03/23 16:29
Analyst Actions: Jefferies Adjusts Prothena PT to $38 From $30, Maintains Buy Rating
MT Newswires
03/15 10:59
Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021
Globe Newswire
03/08 16:05
Seeking Alpha Catalyst Watch
SA Breaking News
03/05 15:15
Premarket analyst action - healthcare
SA Breaking News
02/26 09:27
--Analyst Actions: RBC Upgrades Prothena to Outperform-Speculative Risk From Sector Perform, Adjusts Price Target to $28 From $14
MT Newswires
02/26 07:54
Prothena Announces Promising New Preclinical and Clinical Data from its Neurodegenerative Programs Selected for Oral Presentations at AD/PD 2021
Globe Newswire
02/24 16:05
Prothena surges as Jefferies sees a 100% upside
SA Breaking News
02/12 13:09
Artelo Biosciences leads healthcare gainers; Conformis and Amicus Therapeutics among losers
SA Breaking News
02/12 12:39
--Analyst Actions: Jefferies Upgrades Prothena to Buy From Hold, Adjusts Price Target to $30 From $15
MT Newswires
02/12 07:44
-- Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q4 Revenue $360,000, vs. Street Est of $0.183M
MT Newswires
02/11 08:00
Prothena Reports Fourth Quarter and Full Year 2020 Financial Results, and Provides Financial Guidance and R&D Update
Globe Newswire
02/11 08:00
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
02/05 16:05
Prothena to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast Conference Call on February 11th
Globe Newswire
02/04 16:05
--Analyst Actions: HC Wainwright Adjusts Price Target on Prothena to $33 From $22, Maintains Buy Rating
MT Newswires
02/04 08:55
After Hours Watch List Scorecard: PRTA, CURI, CRUS
MT Newswires
02/02 17:34
GME, SAVA, AMC and OCGN among midday movers
SA Breaking News
02/02 12:40
--Analyst Actions: Oppenheimer Adjusts Prothena PT to $35 From $25, Maintains Outperform Rating
MT Newswires
02/02 10:40
Prothena shares rise 30% premarket following upgrade at BTIG
SA Breaking News
02/02 08:48
INO, VXRT, BTU and TTM among premarket gainers
SA Breaking News
02/02 08:25
--Analyst Actions: BTIG Upgrades Prothena to Buy From Neutral; Price Target is $29
MT Newswires
02/02 08:24
MT Newswires After Hours Watch List: PRTA, CURI, CRUS
MT Newswires
02/01 17:53
PRTA, RMBS, NERV and GPRO among after-hours movers
SA Breaking News
02/01 17:53
Prothena Proceeds With Confirmatory Phase 3 Study of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis
MT Newswires
02/01 16:59
Prothena plans to initiate its late-stage AFFIRM-AL study by mid 2021
SA Breaking News
02/01 16:39
Prothena Announces Confirmatory Phase 3 AFFIRM-AL Study of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis under SPA Agreement with FDA
Globe Newswire
02/01 16:15
Sector Update: Consumer Staples, Discretionary Stocks Closing Gap Slightly Just Ahead of Tuesday's Close
MT Newswires
01/12 15:54
Sector Update: Consumer Discretionary Stocks Posting Sizable Gains
MT Newswires
01/12 13:36
--Analyst Actions: Oppenheimer Adjusts Prothena's Price Target to $25 From $20, Maintains Outperform Rating
MT Newswires
12/10 11:09
Prothena Reports Positive Data From Phase 1 Study of PRX004 to Treat ATTR Amyloidosis; Shares Surge 25% Pre-Bell
MT Newswires
12/09 08:56
Prothena's immunotherapy show slowing neuropathy progression in long-term amyloidosis study
SA Breaking News
12/09 08:38
Prothena Reports Positive 9 Month Results from Phase 1 Long-term Extension Study of PRX004, the First Investigational Anti-Amyloid Immunotherapy for the Treatment of ATTR Amyloidosis
Globe Newswire
12/09 08:00
Analyst Actions: HC Wainwright Starts Prothena at Buy With $22 Price Target
MT Newswires
12/07 08:00
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
12/04 16:05
--Analyst Actions: Oppenheimer Adjusts Prothena PT to $20 From $18, Maintains Outperform Rating
MT Newswires
11/05 12:23
-- Earnings Flash (PRTA) PROTHENA CORPORATION Reports Q3 Revenue $157,000, vs. Street Est of $0.193M
MT Newswires
11/04 16:41
Prothena Reports Third Quarter 2020 Financial Results and Provides R&D Update
Globe Newswire
11/04 16:05
BIIB, XPEV, CXW and PVAC among midday movers
SA Breaking News
11/04 12:40
Prothena Announces Presentations on Two Programs from its Alzheimer’s Disease Portfolio at CTAD 2020
Globe Newswire
11/04 08:30
Prothena to Report Third Quarter 2020 Financial Results on November 4
Globe Newswire
10/28 16:05
Midday Report: Wall Street Slightly Higher; Snap Hits Record High
MT Newswires
10/21 12:46
Analyst Actions: Cantor Fitzgerald Adjusts Prothena's Price Target to $24 From $20, Keeps at Overweight
MT Newswires
10/21 08:33
Prothena, Roche to Advance Prasinezumab into Late-Stage Trial in Parkinson's Disease -- Stock Jumps 11% After-Hours
MT Newswires
10/20 17:54
Roche to advance development of Parkinson's candidate despite underwhelming data
SA Breaking News
10/20 16:44
Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson’s Disease
Globe Newswire
10/20 16:05
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
10/02 16:05
Prothena to Hold Investor Webcast to Discuss Results from Phase 2 PASADENA Study Presented at the International Parkinson and Movement Disorder Society's MDS Virtual Congress
Globe Newswire
09/15 08:30
Seeking Alpha Catalyst Watch
SA Breaking News
09/11 15:30
Prothena Says Parkinson's Disease Treatment Fails to Meet Primary Endpoint But Drug May Slow Disease Progression
MT Newswires
09/11 10:59
Prasinezumab Slows Progression on Measures of Parkinson’s Disease in Phase 2 Study
Globe Newswire
09/11 08:30
Prothena to Present at the 2020 Cantor Virtual Global Healthcare Conference on September 15
Globe Newswire
09/08 16:05
Prothena Announces Updated Timing of Presentation for Phase 2 PASADENA Study Results at International Congress of Parkinson’s Disease and Movement Disorders
Globe Newswire
09/03 16:05
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
09/02 16:05
--Analyst Actions: Oppenheimer Lifts Prothena PT to $18 From $16, Maintains Outperform Rating
MT Newswires
08/10 11:14
-- Earnings Flash (PRTA) PROTHENA CORP PLC Reports Q2 Revenue $0.2M, vs. Street Est of $0.143M
MT Newswires
08/06 16:21
Prothena Reports Second Quarter 2020 Financial Results and Provides R&D Update
Globe Newswire
08/06 16:05
Prothena Announces Phase 2 PASADENA Study Results to be Presented at International Congress of Parkinson’s Disease and Movement Disorders
Globe Newswire
08/05 16:05
Prothena to Report Second Quarter 2020 Financial Results on August 6
Globe Newswire
07/30 16:05
--Analyst Actions: Oppenheimer Upgrades Prothena to Outperform From Market Perform, Sets $16 Price Target
MT Newswires
07/09 11:33
Altimmune leads healthcare gainers; CTI BioPharma and Evolus among losers
SA Breaking News
07/09 11:00
Prothena to Present at the Jefferies Virtual Healthcare Conference on June 3
Globe Newswire
05/27 16:05
--Analyst Actions: RBC Capital Cuts Prothena PT to $12 From $13, Maintains Sector Perform Rating
MT Newswires
05/07 09:24
Prothena Reports First Quarter 2020 Financial Results and Provides R&D Update and Updated Financial Guidance
Globe Newswire
05/06 16:05
Prothena to Report First Quarter 2020 Financial Results on May 6
Globe Newswire
04/29 16:05
Prothena Provides Additional Information Regarding Upcoming Annual General Meeting of Shareholders in Response to COVID-19
Globe Newswire
04/24 16:30
Sector Update: Health Care Stocks Still Adding Support in Late Trade
MT Newswires
04/22 15:51
Sector Update: Moderate Gains for Health Care Stocks
MT Newswires
04/22 13:44
SmileDirectClub and Immunic among healthcare gainers; Biogen among losers
SA Breaking News
04/22 11:00
Prothena down 16% as Parkinson's drug flops in mid-stage study
SA Breaking News
04/22 10:11
Prothena Shares Fall 16% as Study of Prasinezumab to Treat Parkinson's Disease Misses Primary Objective
MT Newswires
04/22 09:58
Update on Phase 2 PASADENA Study of Prasinezumab (PRX002/RG7935) in Parkinson’s Disease
Globe Newswire
04/22 09:15
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
04/03 16:05
Baseline Data from Phase 2 PASADENA Study of Prasinezumab (PRX002/RG7935) in Parkinson’s Disease to be Presented at AAT-AD/PD
Globe Newswire
03/31 16:05
Prothena Announces Appointment of Brandon Smith as Chief Business Officer
Globe Newswire
03/03 16:05
Prothena Q4 Results Top Street Estimates
MT Newswires
02/13 05:05
Prothena EPS beats by $0.06, beats on revenue
SA Breaking News
02/12 16:06
Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update
Globe Newswire
02/12 16:05
NIO, SDRL, CTIC and AGRX among midday movers
SA Breaking News
12/24 11:17
Thinking about buying stock in Bank of America, LYFT, Prothena Corporation, Rite Aid, or AT&T?
PR Newswire
12/23 09:31
RAD, CAMP, ABEO and MRNS in midday movers
SA Breaking News
12/20 12:38
Prothena Announces Appointment of Oleg Nodelman to its Board of Directors
Globe Newswire
12/05 16:05
Prothena up 8% on Evercore upgrade
SA Breaking News
11/19 11:16
Evercore downgrades bluebird bio and Clovis in premarket analyst action
SA Breaking News
11/19 08:12
--Analyst Actions: Evercore ISI Upgrades Prothena to Outperform From In-Line; Price Target is $14
MT Newswires
11/19 08:02
Prothena Reports Third Quarter 2019 Financial Results and Provides R&D Update
Globe Newswire
11/05 16:05
Prothena to Report Third Quarter 2019 Financial Results on November 5
Globe Newswire
10/29 16:05
Labaton Sucharow LLP and Levi & Korsinsky LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Ordinary Shares of Prothena Corporation plc in In re Prothena Corporation plc Securities Litigation, No. 1:18-cv-06425-ALC
PR Newswire
10/07 09:00
BCOV, FNKO and SHOP among after hour movers
SA Breaking News
09/16 17:32
Close Update: Stocks Slump Tuesday as Trade War Anxiety, Recession Alarm Bells Help Send Market Lower
MT Newswires
08/27 16:23
Microcaps mostly among midday movers
SA Breaking News
08/27 12:35
Prothena leads healthcare gainers; Mallinckrodt and Endo International among losers
SA Breaking News
08/27 11:00
Prothena Shareholder EcoR1 Capital Reveals Nearly 24% Stake
MT Newswires
08/27 05:21
EcoR1 reports 23.6% stake in Prothena
SA Breaking News
08/26 16:07
Prothena to Report Second Quarter 2019 Financial Results on August 6
Globe Newswire
07/30 16:05
Prothena Announces Appointment of Paula K. Cobb to its Board of Directors
Globe Newswire
07/01 16:05
Prothena to Participate in the Jefferies Healthcare Conference
Globe Newswire
05/30 16:05
Prothena files for $150M shelf stock
SA Breaking News
05/22 21:59
--Prothena Plans to Raise up to $150 Mln via Share Sale, Filing Shows
MT Newswires
05/22 17:14
Prothena beats by $0.10, misses on revenue
SA Breaking News
05/07 16:42
Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update
Globe Newswire
05/07 16:05
Prothena to Report First Quarter 2019 Financial Results on May 7
Globe Newswire
04/30 16:05
Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
Globe Newswire
04/18 16:05
Analysis: Positioning to Benefit within Cleveland-Cliffs, Wix, F5 Networks, Prothena Corporation plc, McCormick & Company, and NII — Research Highlights Growth, Revenue, and Consolidated Results
Globe Newswire
04/03 08:25
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Prothena Corporation plc and Encourages Investors who Purchased Shares in the March 2017 Secondary Offering to Contact the Firm
Globe Newswire
03/14 17:15
Prothena to Participate in Upcoming March Healthcare Conferences
Globe Newswire
03/05 16:05
Prothena Q4 Mixed vs Estimates, 2019 Loss Guidance Wider Than Consensus
MT Newswires
02/14 17:18
Prothena beats by $0.38, misses on revenue
SA Breaking News
02/14 16:09
Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update
Globe Newswire
02/14 16:05
Prothena to Report Fourth Quarter and Full Year 2018 Financial Results and Host Webcast Conference Call on February 14
Globe Newswire
02/04 16:05
Report: Developing Opportunities within Hyatt Hotels, Carter's, Globus Medical, Switch, Prothena Corporation plc, and Assurant — Future Expectations, Projections Moving into 2019
Globe Newswire
01/30 08:15
Prothena beats by $0.36, beats on revenue
SA Breaking News
11/06 16:15
Prothena Reports Third Quarter 2018 Financial Results and Provides R&D Update
Globe Newswire
11/06 16:05
Prothena to Report Third Quarter 2018 Financial Results on November 6
Globe Newswire
10/30 16:05
Factors of Influence in 2018, Key Indicators and Opportunity within 1-800 FLOWERS.COM, Bojangles', Prothena Corporation plc, Lydall, Daktronics, and ServiceSource International — New Research Emphasizes Economic Growth
Globe Newswire
10/16 09:10
The Law Offices of Howard G. Smith Reminds Investors of Extended Lead Plaintiff Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA)
Globe Newswire
09/13 18:17
September 17th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA)
Globe Newswire
09/06 20:21
EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Prothena Corporation plc – PRTA
Business Wire
09/02 09:12
Glancy Prongay & Murray LLP Announces Extended Lead Plaintiff Deadline in Securities Class Action on Behalf of Prothena Corporation plc Investors (PRTA)
Globe Newswire
08/31 20:24
Investor Expectations to Drive Momentum within Rapid7, 1-800 FLOWERS.COM, SMART Global, Prothena Corporation plc, Amphastar Pharmaceuticals, and Silvercorp Metals — Discovering Underlying Factors of Influence
Globe Newswire
08/20 08:00
Notice of Voluntary Dismissal of Class Action Concerning Prothena Corporation
Globe Newswire
08/09 14:39
Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update
Globe Newswire
08/07 16:05
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Prothena Corporation Investors and Set a Lead Plaintiff Deadline of October 5, 2018
Globe Newswire
08/06 17:56
Prothena to Report Second Quarter 2018 Financial Results on August 7
Globe Newswire
07/31 16:05
Investor Alert: Kaplan Fox Announces Investigation Of Prothena Corporation plc
PR Newswire
07/24 14:52
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Prothena Corporation plc (PRTA) & Lead Plaintiff Deadline - September 17, 2018
PR Newswire
07/18 12:15
Labaton Sucharow LLP Files Securities Class Action Lawsuit on Behalf of Prothena Corporation plc Investors
Globe Newswire
07/17 15:46
CLASS ACTION DEADLINE MONDAY for PRTA and FLR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
07/16 11:26
SHAREHOLDER ALERT – PRTA SYMC PPG MFGP FLR ATEN REPH DB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Globe Newswire
07/15 00:00
The Law Offices of Howard G. Smith Reminds Investors of July 16th Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA)
Globe Newswire
07/13 21:07
CLASS ACTION DEADLINE MONDAY for PRTA and SYMC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
07/13 19:00
SHAREHOLDER ALERT – PRTA SYMC PPG MFGP FLR DB QCOM NWL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Globe Newswire
07/13 12:40
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors With Losses in Excess of $2,000,000 of Class Action Against Prothena Corporation plc (PRTA) & Lead Plaintiff Deadline – July 16, 2018
Globe Newswire
07/13 10:00
July 16th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA)
Globe Newswire
07/12 19:24
UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PRTA, PPG, DB, PCG, and TAL
Globe Newswire
07/12 15:58
MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Prothena Corporation plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Business Wire
07/11 15:27
SHAREHOLDER ALERT – PRTA SYMC MFGP ANW ORA PCG TAL FLKS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Globe Newswire
07/11 15:08
CLASS ACTION UPDATE for PRTA and ATEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
07/11 14:01